Research unit
Project number
59256.1 IP-LS
Project title
Defining the pharmacology, safety, and dosing of #PB-FC# a novel bacterial drug-candidate for reversal of dysbiosis in acute graft-versus-host disease
Project status In Process
Start date 01.03.2022
End date 01.08.2024
Granted total costs 726'604.00  CHF
Section 60 Life Sciences
Project category Project
Research type Applied research and development
NABS classification Industrial production and technology
Research disciplines
100 % T410 Pharmaceuticals and related technologies

Last modification of the project